Novo Nordisk to Lay off 400 to Focus on Innovation

Novo Nordisk to Lay off 400 to Focus on Innovation

Source: 
BioSpace
snippet: 

Novo Nordisk is laying off 400 staffers so it can shift funds toward biological and technological innovation. The layoffs will occur in Denmark and China. Last week, the company announced that it plans to invest about 115 million pounds over a 10-year period in a new research-and-development facility in Oxford (UK) that will create up to 100 research jobs.